【大行评级丨花旗:2024财年业绩好过预期,升中国人寿目标价至17.9港元】花旗研究报告,分别将中国人寿(2628.HK)2025及26财年的每股盈利预测下调1%及7%,以反映投资收入的预期较低;另将其目标价由17.7港元升至17.9港元,以反映2024财年业绩好过预期;维持“买入”评级。

金融界
16 May
花旗研究报告,分别将中国人寿(2628.HK)2025及26财年的每股盈利预测下调1%及7%,以反映投资收入的预期较低;另将其目标价由17.7港元升至17.9港元,以反映2024财年业绩好过预期;维持“买入”评级。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10